Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Other Accumulated Expenses (2016 - 2026)

Gyre Therapeutics has reported Other Accumulated Expenses over the past 15 years, most recently at $227000.0 for Q4 2025.

  • Quarterly Other Accumulated Expenses changed 0.0% to $227000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $227000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $227000.0 for FY2025, 0.0% changed from the prior year.
  • Other Accumulated Expenses was $227000.0 for Q4 2025 at Gyre Therapeutics, roughly flat from $228000.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $8.1 million in Q3 2021 and troughed at $118000.0 in Q4 2022.
  • The 5-year median for Other Accumulated Expenses is $1.1 million (2022), against an average of $2.1 million.
  • Year-over-year, Other Accumulated Expenses plummeted 97.77% in 2022 and then skyrocketed 1060.17% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $4.1 million in 2021, then crashed by 97.1% to $118000.0 in 2022, then skyrocketed by 1060.17% to $1.4 million in 2023, then plummeted by 83.42% to $227000.0 in 2024, then changed by 0.0% to $227000.0 in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Other Accumulated Expenses are $227000.0 (Q4 2025), $228000.0 (Q3 2025), and $219000.0 (Q2 2025).